We use cookies on our website. Carry on browsing if you’re happy with this or find out more



Driving new boundaries in drug development

Identifying and investigating new treatments to improve patient outcomes

Our pipeline

We are building a rich pipeline of assets in four main therapeutic spaces: immune diseases, immuno-oncology, haematology and infectious diseases. Our most advanced assets entered development in 2015 with first proof of concepts scheduled for readout by 2019.

Download Pipeline PDF

Read about our progress in our Posters and publications page

Learn more